Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables, and Other), Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), And Segment Forecasts, 2019 - 2026

Published: Oct, 2019 | Pages: 190 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global peptide synthesis market size is expected to reach USD 1,011.99 million by 2026 growing at a CAGR of 13.0%, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.

A surge in the demand for custom peptide synthesis has been observed in the recent years; several companies operating in this industry offer products and services associated with custom peptide synthesis. For instance, a UK based company namely, Almac Group offers peptide synthesis suitable for research use. Constantly growing demand and evolving market landscape for custom peptides is set to offer lucrative opportunities for the market growth. The suppliers are expanding their production capacity to suffice the increasing demand for high quality peptides across research and therapeutics areas.

Rising focus of the pharmaceutical companies towards the development of novel biologics and shifting the peptide drugs from the pipeline stage to commercial scale further strengthens the market growth. Increase in the number of research activities performed on exploring the potential of high-quality peptides and peptide libraries in the development of vaccines and biomarker discovery heavily contributes to the revenue generated by the global peptide synthesis market. Moreover, introduction of modified peptides (GMP peptides) that possess enhanced stability and pharmacokinetic properties in the market is expected to maintain the double-digit market growth throughout the forecast period.

Therapeutic peptide development has witnessed remarkable growth in the recent years, this is further driven by significant increase in the patient pool suffering from cardiovascular and metabolic diseases. This has propelled the discovery of bioactive peptides exponentially which further drives the market demand.

Further key findings from the study suggest:

• Reagents & consumables accounted for the highest revenue generated in 2018 and is anticipated to maintain this trend throughout the forecast period.

• Peptide synthesis equipment has registered fastest growth during the forecast period.

• Peptide synthesizers segment serves to be a major contributor to the revenue generated by equipment in the global market and is anticipated to grow at highest CAGR of 13.91% from 2019-2026 among other peptide synthesis equipment.

• Liquid phase peptide synthesis (LPPS) technology dominated the peptide synthesis market in 2018 and is expected to continue this dominance throughout the forecast period.

• Therapeutic peptide synthesis has garnered largest share in the market in 2018 and is anticipated to maintain this trend throughout the forecast period.

• North America region has generated highest revenue in 2018 and is expected to maintain this dominance throughout the forecast period; sufficient presence of skilled professionals along with the strong network of peptide synthesis manufacturers is attributive to this region's dominance in the global market.

• APAC is expected to offer lucrative opportunities for the market expansion, attributed to rising focus on the development of peptide therapeutics.

• Large patient pool for cardiovascular and metabolic diseases in the APAC region has significantly contributed to the revenue generated, contributing to the highest CAGR registered during the forecast period.

• Some of the key market participants are Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, and Novo Nordisk among others.

 Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Information procurement
                   1.2 Information or Data Analysis
                   1.3 Market Formulation & Validation

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends& Scope
                   3.1 Market Segmentation & Scope
                       3.1.1 Market driver analysis
                           3.1.1.1 Strong peptide therapeutics pipeline
                       3.1.2 Market restraint analysis
                           3.1.2.1 Challenges pertaining to large-scale peptide synthesis
                   3.2 Penetration & Growth Prospect Mapping for Products, 2018
                   3.3 Peptide synthesis Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                   3.4 Industry Analysis - Porter's

Chapter 4 Peptide Synthesis: Product Estimates & Trend Analysis
                   4.1 Peptide Synthesis Market: Product Movement Analysis
                   4.2 Equipment
                       4.2.1 Peptide synthesis market for equipment, 2014 - 2026 (USD Million)

Chapter 5 Peptide Synthesis: Application Estimates & Trend Analysis
                   5.1 Peptide Synthesis Market: Application Movement Analysis
                   5.2 Therapeutics
                       5.2.1 Peptide synthesis market for therapeutics, 2014 - 2026 (USD Million)

Chapter 6 Peptide Synthesis: Technology Estimates & Trend Analysis
                   6.1 Peptide Synthesis Market: Technology Movement Analysis
                   6.2 Solid Phase Peptide Synthesis (SPPS)
                       6.2.1 Solid phase peptide synthesis (SPPS) market, 2014 - 2026 (USD Million)

Chapter 7 Peptide Synthesis: End-use Estimates & Trend Analysis
                   7.1 Peptide Synthesis Market: End-use Movement Analysis
                   7.2 Pharmaceutical and Biotechnology Companies
                       7.2.1 Peptide synthesis market for pharmaceutical and biotechnology companies, 2014 - 2026 (USD Million)

Chapter 8 Peptide synthesis: Regional Estimates & Trend Analysis, by Product, Technology, Application and End Use
                   8.1 Peptide Synthesis Market share by region, 2018 & 2026
                   8.2 North America
                       8.2.1 North America peptide synthesis market, 2014 - 2026 (USD Million)
                       8.2.2 U.S.
                           8.2.2.1 U.S. peptide synthesis market, 2014 - 2026 (USD Million)
                       8.2.3 Canada
                           8.2.3.1 Canada peptide synthesis market, 2014 - 2026 (USD Million)
                   8.3 Europe
                       8.3.1 Europe peptide synthesis market, 2014 - 2026 (USD Million)
                       8.3.2 UK
                           8.3.2.1 UK peptide synthesis market, 2014 - 2026 (USD Million)
                       8.3.3 Germany
                           8.3.3.1 Germany peptide synthesis market, 2014 - 2026 (USD Million)
                       8.3.4 France
                           8.3.4.1 France peptide synthesis market, 2014 - 2026 (USD Million)
                       8.3.5 Italy
                           8.3.5.1 Italy peptide synthesis market, 2014 - 2026 (USD Million)
                   8.4 Asia Pacific
                       8.4.1 Asia Pacific peptide synthesis market, 2014 - 2026 (USD Million)
                       8.4.2 Japan
                           8.4.2.1 Japan peptide synthesis market, 2014 - 2026 (USD Million)
                       8.4.3 China
                           8.4.3.1 China peptide synthesis market, 2014 - 2026 (USD Million)
                       8.4.4 India
                           8.4.4.1 India peptide synthesis market, 2014 - 2026 (USD Million)
                       8.4.5 Australia
                           8.4.5.1 Australia peptide synthesis market, 2014 - 2026 (USD Million)
                   8.5 Latin America
                       8.5.1 Latin America peptide synthesis market, 2014 - 2026 (USD Million)
                       8.5.2 Brazil
                           8.5.2.1 Brazil peptide synthesis market, 2014 - 2026 (USD Million)
                       8.5.3 Mexico
                           8.5.3.1 Mexico peptide synthesis market, 2014 - 2026 (USD Million)
                   8.6 MEA
                       8.6.1 MEA peptide synthesis market, 2014 - 2026 (USD Million)
                       8.6.2 South Africa
                           8.6.2.1 South Africa peptide synthesis market, 2014 - 2026 (USD Million)
                       8.6.3 Saudi Arabia
                           8.6.3.1 Saudi Arabia peptide synthesis market, 2014 - 2026 (USD Million)

Chapter 9 Competitive Landscape
                   9.1 Strategy Framework
                   9.2 Market Participation Categorization
                   9.3 Company Profiles
                       9.3.1 Genscript Biotech
                           9.3.1.1 Company overview
                           9.3.1.2 Financial performance
                           9.3.1.3 Product benchmarking
                           9.3.1.4 Strategic initiatives
                       9.3.2 Merck KGaA
                           9.3.2.1 Company overview
                           9.3.2.2 Financial performance
                           9.3.2.3 Product benchmarking
                           9.3.2.4 Strategic initiatives
                       9.3.3 Bachem Holdings
                           9.3.3.1 Company overview
                           9.3.3.2 Financial performance
                           9.3.3.3 Product benchmarking
                           9.3.3.4 Strategic initiatives
                       9.3.4 Biotage
                           9.3.4.1 Company overview
                           9.3.4.2 Financial performance
                           9.3.4.3 Product benchmarking
                           9.3.4.4 Strategic initiatives
                       9.3.5 CEM Corporation
                           9.3.5.1 Company overview
                           9.3.5.2 Financial performance
                           9.3.5.3 Product benchmarking
                           9.3.5.4 Strategic initiatives
                       9.3.6 Thermo Fisher Scientific
                           9.3.6.1 Company overview
                           9.3.6.2 Financial performance
                           9.3.6.3 Product benchmarking
                           9.3.6.4 Strategic initiatives
                       9.3.7 Creative Diagnostics
                           9.3.7.1 Company overview
                           9.3.7.2 Financial performance
                           9.3.7.3 Product benchmarking
                           9.3.7.4 Strategic initiatives
                       9.3.8 Polypeptide Group
                           9.3.8.1 Company overview
                           9.3.8.2 Financial performance
                           9.3.8.3 Product benchmarking
                           9.3.8.4 Strategic initiatives
                       9.3.9 Syngene
                           9.3.9.1 Company overview
                           9.3.9.2 Financial performance
                           9.3.9.3 Product benchmarking
                           9.3.9.4 Strategic initiatives
                       9.3.10 PuroSynth
                           9.3.10.1 Company overview
                           9.3.10.2 Financial performance
                           9.3.10.3 Product benchmarking
                           9.3.10.4 Strategic initiatives
                       9.3.11 Lonza
                           9.3.11.1 Company overview
                           9.3.11.2 Financial performance
                           9.3.11.3 Product benchmarking
                           9.3.11.4 Strategic initiatives
                       9.3.12 MP Biomedicals
                           9.3.12.1 Company overview
                           9.3.12.2 Financial performance
                           9.3.12.3 Product benchmarking
                           9.3.12.4 Strategic initiatives
                       9.3.13 Novo Nordisk A/S
                           9.3.13.1 Company overview
                           9.3.13.2 Financial performance
                           9.3.13.3 Product benchmarking
                           9.3.13.4 Strategic initiatives

List of Tables

TABLE 1 North America peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 2 North America peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 3 North America peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 4 North America peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 5 U.S. peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 6 U.S. peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 7 U.S. peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 8 U.S. peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 9 Canada peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 10 Canada peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 11 Canada peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 12 Canada peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 13 Europe peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 14 Europe peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 15 Europe peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 16 Europe peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 17 UK peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 18 UK peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 19 UK peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 20 UK peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 21 Germany peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 22 Germany peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 23 Germany peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 24 Germany peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 25 France peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 26 France peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 27 France peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 28 France peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 29 Italy peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 30 Italy peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 31 Italy peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 32 Italy peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 33 Asia Pacific peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 34 Asia Pacific peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 35 Asia Pacific peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 36 Asia Pacific peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 37 Japan peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 38 Japan peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 39 Japan peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 40 Japan peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 41 China peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 42 China peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 43 China peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 44 China peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 45 India peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 46 India peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 47 India peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 48 India peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 49 Australia peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 50 Australia peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 51 Australia peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 52 Australia peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 53 Latin America peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 54 Latin America peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 55 Latin America peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 56 Latin America peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 57 Brazil peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 58 Brazil peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 59 Brazil peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 60 Brazil peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 61 Mexico peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 62 Mexico peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 63 Mexico peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 64 Mexico peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 65 MEA peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 66 MEA peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 67 MEA peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 68 MEA peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 69 South Africa peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 70 South Africa peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 71 South Africa peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 72 South Africa peptide synthesis market, by end-use, 2014 - 2026 (USD Million)
TABLE 73 Saudi Arabia peptide synthesis market, by product, 2014 - 2026 (USD Million)
TABLE 74 Saudi Arabia peptide synthesis market, by technology, 2014 - 2026 (USD Million)
TABLE 75 Saudi Arabia peptide synthesis market, by application, 2014 - 2026 (USD Million)
TABLE 76 Saudi Arabia peptide synthesis market, by end-use, 2014 - 2026 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for products, 2018
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Peptide synthesis market: Product type outlook key takeaways
FIG. 16 Peptide synthesis market: Product market movement analysis
FIG. 17 Global peptide synthesis market for equipment, 2014 - 2026 (USD Million)
FIG. 18 Peptide synthesis market: Application outlook key takeaways
FIG. 19 Peptide synthesis market: Application market movement analysis
FIG. 20 Global peptide synthesis market for therapeutics, 2014 - 2026 (USD Million)
FIG. 21 Peptide synthesis market: Technology outlook key takeaways
FIG. 22 Peptide synthesis market: Technology market movement analysis
FIG. 23 Global solid phase peptide synthesis (SPPS) market, 2014 - 2026 (USD Million)
FIG. 24 Peptide synthesis market: End-use outlook key takeaways
FIG. 25 Peptide synthesis market: End-use market movement analysis
FIG. 26 Global peptide synthesis market for pharmaceutical and biotechnology companies, 2014 - 2026 (USD Million)
FIG. 27 Regional market place: Key takeaways
FIG. 28 Peptide synthesis market by region: Regional movement analysis
FIG. 29 North America peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 30 U.S. peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 31 Canada peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 32 Europe peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 33 UK peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 34 Germany peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 35 France peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 36 Italy peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 37 Asia Pacific peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 38 Japan peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 39 China peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 40 India peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 41 Australia peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 42 Latin America peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 43 Brazil peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 44 Mexico peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 45 MEA peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 46 South Africa peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 47 Saudi Arabia peptide synthesis market, 2014 - 2026 (USD Million)
FIG. 48 Strategy framework
FIG. 49 Participant categorization